Published in J Immunogenet on June 01, 1981
The in vitro production of anti-nuclear antibodies by human peripheral blood mononuclear cells. Demonstration of T cell requirement and soluble inducing factor(s) for anti-nuclear antibodies triggering in patients with systemic lupus erythematosus. Clin Exp Immunol (1984) 0.83
The induction of human antinuclear antibodies by D-penicillamine: activation of inducer helper T cells in the absence of irradiation sensitive suppressor T cells. Clin Exp Immunol (1986) 0.75
Ras pathway specificity is determined by the integration of multiple signal-activated and tissue-restricted transcription factors. Cell (2000) 2.60
Activation of cyclin A-dependent protein kinases during apoptosis. Proc Natl Acad Sci U S A (1994) 2.29
Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamily. Proc Natl Acad Sci U S A (1992) 2.17
Two distinct mechanisms for the SCL gene activation in the t(1;14) translocation of T-cell leukemias. Genes Chromosomes Cancer (1990) 1.85
T cell receptor gamma/delta+ lymphocyte subsets during HIV infection. Clin Exp Immunol (1989) 1.72
Murine sarcoma virus pseudotypes acquire a determinant specifying N or B tropism from leukaemia virus during rescue. Nature (1975) 1.68
Dual susceptibility of A 3T3 mouse cell line to infection by N- and B-tropic murine leukemia virus: apparent lack of expression of the FV-1 gene. Int J Cancer (1974) 1.65
Early immune responses accompanying human asymptomatic Ebola infections. Clin Exp Immunol (2001) 1.65
Sequences and diversity of human T cell receptor beta chain variable region genes. J Exp Med (1986) 1.62
Frequent c-fms activation by proviral insertion in mouse myeloblastic leukaemias. Nature (1987) 1.59
Combinatorial signaling codes for the progressive determination of cell fates in the Drosophila embryonic mesoderm. Genes Dev (1998) 1.59
Thrombopoietin activates a STAT5-like factor in hematopoietic cells. EMBO J (1995) 1.55
Donation of N- or B-tropic phenotype to NB-tropic murine leukemia virus during mixed infections. J Virol (1977) 1.52
Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells. Blood (2000) 1.52
Heartbroken is a specific downstream mediator of FGF receptor signalling in Drosophila. Development (1998) 1.50
Identification of tyrosine residues within the intracellular domain of the erythropoietin receptor crucial for STAT5 activation. EMBO J (1996) 1.49
Expression, structure, and function of the CD23 antigen. Adv Immunol (1991) 1.46
Carboxyl-terminal and central regions of human immunodeficiency virus-1 NEF recognized by cytotoxic T lymphocytes from lymphoid organs. An in vitro limiting dilution analysis. J Clin Invest (1992) 1.43
T lymphocyte subsets in primary antiphospholipid syndrome. J Rheumatol (1994) 1.43
Proteasomes regulate erythropoietin receptor and signal transducer and activator of transcription 5 (STAT5) activation. Possible involvement of the ubiquitinated Cis protein. J Biol Chem (1998) 1.39
Evidence for a cytotoxic T-lymphocyte alveolitis in human immunodeficiency virus-infected patients. AIDS (1988) 1.37
IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line. Oncogene (1999) 1.37
Signalling by the Drosophila epidermal growth factor receptor is required for the specification and diversification of embryonic muscle progenitors. Development (1998) 1.36
Cell-mediated suppression of HIV-specific cytotoxic T lymphocytes. J Immunol (1989) 1.33
A sequence of the CIS gene promoter interacts preferentially with two associated STAT5A dimers: a distinct biochemical difference between STAT5A and STAT5B. Mol Cell Biol (1998) 1.32
Early protective effect of CCR-5 delta 32 heterozygosity on HIV-1 disease progression: relationship with viral load. The SEROCO Study Group. AIDS (1997) 1.30
Control of thrombopoietin-induced megakaryocytic differentiation by the mitogen-activated protein kinase pathway. Mol Cell Biol (1997) 1.29
Soluble CD23 (Fc epsilon RII) and interleukin 1 synergistically induce early human thymocyte maturation. J Exp Med (1990) 1.26
Thrombopoietin-mediated sustained activation of extracellular signal-regulated kinase in UT7-Mpl cells requires both Ras-Raf-1- and Rap1-B-Raf-dependent pathways. Mol Cell Biol (2001) 1.23
CD4+CD7-CD57+ T cells: a new T-lymphocyte subset expanded during human immunodeficiency virus infection. Blood (1992) 1.23
fim-1 and fim-2: two new integration regions of Friend murine leukemia virus in myeloblastic leukemias. J Virol (1986) 1.18
Alternative splicing of the Evi-1 zinc finger gene generates mRNAs which differ by the number of zinc finger motifs. Oncogene (1990) 1.18
The KUP gene, located on human chromosome 14, encodes a protein with two distant zinc fingers. Nucleic Acids Res (1991) 1.18
Dual functions of the heartless fibroblast growth factor receptor in development of the Drosophila embryonic mesoderm. Dev Genet (1998) 1.17
Viral expression in two myelomonocytic cell lines obtained from long-term bone marrow culture infected with the Friend polycythemia-inducing virus (FV-P). Virology (1982) 1.16
SIAH-1 interacts with alpha-tubulin and degrades the kinesin Kid by the proteasome pathway during mitosis. Oncogene (2000) 1.15
Multimeric structure of the membrane erythropoietin receptor of murine erythroleukemia cells (Friend cells). Cross-linking of erythropoietin with the spleen focus-forming virus envelope protein. J Biol Chem (1991) 1.12
Constitutively active STAT5 variants induce growth and survival of hematopoietic cells through a PI 3-kinase/Akt dependent pathway. Oncogene (2001) 1.11
Erythropoietin induces the tyrosine phosphorylation of GAB1 and its association with SHC, SHP2, SHIP, and phosphatidylinositol 3-kinase. Blood (1999) 1.11
Functional regions of the mouse thrombopoietin receptor cytoplasmic domain: evidence for a critical region which is involved in differentiation and can be complemented by erythropoietin. Mol Cell Biol (1996) 1.11
Genetic control of sensitivity to Moloney-virus-induced leukemias in mice. I. Demonstration of multigenic control. Int J Cancer (1978) 1.06
Critical analysis of T cell subset and function evaluation in patients with persistent generalized lymphadenopathy in groups at risk for AIDS. Clin Exp Immunol (1984) 1.04
[Determination of salivary immunoglobulins. Its value in the diagnosis of Gougerot-Sjögren syndrome]. Rev Rhum Mal Osteoartic (1977) 1.04
A soluble factor released by CD8+CD57+ lymphocytes from bone marrow transplanted patients inhibits cell-mediated cytolysis. Blood (1991) 1.04
Evi-1 expression in leukemic patients with rearrangements of the 3q25-q28 chromosomal region. Leukemia (1992) 1.03
Internalization of HIV glycoprotein gp120 is associated with down-modulation of membrane CD4 and p56lck together with impairment of T cell activation. J Immunol (1992) 1.02
Human immunodeficiency virus-1 glycoproteins gp120 and gp160 specifically inhibit the CD3/T cell-antigen receptor phosphoinositide transduction pathway. J Clin Invest (1990) 1.02
hSiah2 is a new Vav binding protein which inhibits Vav-mediated signaling pathways. Mol Cell Biol (1999) 1.02
Frequent involvement of the fim-3 region in Friend murine leukemia virus-induced mouse myeloblastic leukemias. J Virol (1987) 1.01
Interactions between IgM antiglobulins and IgG antinuclear antibodies. Some aspects of D-penicillamine activities. Clin Exp Immunol (1979) 1.01
Fully functional NK cells after unrelated cord blood transplantation. Leukemia (2009) 1.01
Increased lung epithelial permeability in HIV-infected patients with isolated cytotoxic T-lymphocytic alveolitis. Am Rev Respir Dis (1990) 1.00
Isolation and characterization of a gp 70+ non producer Friend tumor cell clone. Biochimie (1983) 1.00
Proteasomes regulate the duration of erythropoietin receptor activation by controlling down-regulation of cell surface receptors. J Biol Chem (2000) 0.99
c-kit mRNA expression in human and murine hematopoietic cell lines. Oncogene (1989) 0.99
Genetic control of sensitivity to Moloney leukemia virus in mice. IV. Phenotypic heterogeneity of the leukemic mice. J Immunol (1980) 0.98
Defective p56Lck activity in T cells from an adult patient with idiopathic CD4+ lymphocytopenia. Int Immunol (2000) 0.98
Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STAT5 activation. EMBO J (1996) 0.98
Vav binding to heterogeneous nuclear ribonucleoprotein (hnRNP) C. Evidence for Vav-hnRNP interactions in an RNA-dependent manner. J Biol Chem (1998) 0.98
The in vitro production and regulation of anti-double stranded DNA antibodies by peripheral blood mononuclear cells from normals and patients with systemic lupus erythematosus. Clin Exp Immunol (1984) 0.97
Reactivity of lymphocytes to a progesterone receptor-specific monoclonal antibody. Cell Immunol (1990) 0.97
CD34-expressing human thymocyte precursors proliferate in response to interleukin-7 but have lost myeloid differentiation potential. Blood (1993) 0.97
p95vav associates with the nuclear protein Ku-70. Mol Cell Biol (1996) 0.96
Interleukin-3, erythropoietin, and prolactin activate a STAT5-like factor in lymphoid cells. J Biol Chem (1995) 0.96
Alveolar CD8+CD57+ lymphocytes in human immunodeficiency virus infection produce an inhibitor of cytotoxic functions. Am J Respir Crit Care Med (1994) 0.95
Consistency of routine measurements of CD4+, CD8+ peripheral blood lymphocytes. J Immunol Methods (1992) 0.95
Human trophoblast cells express CD4 and are permissive for productive infection with HIV-1. Clin Exp Immunol (1992) 0.95
High level of tyrosine protein kinase in a murine lymphoma cell line induced by Moloney leukemia virus. EMBO J (1982) 0.94
Evidence for expression of two distinct T cell receptor beta-chain transcripts in a human diphtheria toxoid-specific T cell clone. J Immunol (1988) 0.94
A single amino acid in the DNA binding regions of STAT5A and STAT5B confers distinct DNA binding specificities. J Biol Chem (1998) 0.94
Erythropoietin induces the association of phosphatidylinositol 3'-kinase with a tyrosine-phosphorylated protein complex containing the erythropoietin receptor. Eur J Biochem (1993) 0.94
Isolation of an early T-cell precursor (CFU-TL) from human bone marrow. Blood (1990) 0.94
Conjunctival biopsy in Sjögren's syndrome: correlations between histological and immunohistochemical features. Histopathology (1988) 0.93
CCR5 delta32 deletion and reduced risk of toxoplasmosis in persons infected with human immunodeficiency virus type 1. The SEROCO-HEMOCO-SEROGEST Study Groups. J Infect Dis (1999) 0.93
Thrombopoietin-induced expression of the glycoprotein IIb gene involves the transcription factor PU.1/Spi-1 in UT7-Mpl cells. J Biol Chem (1997) 0.92
Erythropoietin induces the tyrosine phosphorylation of insulin receptor substrate-2. An alternate pathway for erythropoietin-induced phosphatidylinositol 3-kinase activation. J Biol Chem (1997) 0.92
Genetic control of sensitivity to Moloney leukemia virus in mice. II. Mapping of three resistant genes within the H-2 complex. J Immunol (1979) 0.91
Structure of the murine erythropoietin receptor complex. Characterization of the erythropoietin cross-linked proteins. J Biol Chem (1991) 0.91
Rearrangements of the Pim-1, c-myc, and p53 genes in Friend helper virus-induced mouse erythroleukemias. Leukemia (1990) 0.91
Expression of MHC class II and Tac antigens on IL2-activated human T cell clones that can stimulate in MLR, AMLR, PLT and can present antigen. Hum Immunol (1986) 0.91
Fim-1, Fim-2/c-fms, and Fim-3, three common integration sites of Friend murine leukemia virus in myeloblastic leukemias, map to mouse chromosomes 13, 18, and 3, respectively. J Virol (1988) 0.90
Cooperation between STAT5 and phosphatidylinositol 3-kinase in the IL-3-dependent survival of a bone marrow derived cell line. Oncogene (2000) 0.90
Role of Gab proteins in phosphatidylinositol 3-kinase activation by thrombopoietin (Tpo). Oncogene (2001) 0.90
Phosphorylations of the subcellular matrix in cells transformed by Rous' sarcoma virus. Eur J Biochem (1982) 0.89
Characterization of mpl cytoplasmic domain sequences required for myeloproliferative leukemia virus pathogenicity. J Virol (1994) 0.89
Immunoregulatory effects of a suppressor factor from healthy pregnant women's lymphocytes after progesterone induction. Cell Immunol (1989) 0.89
[Waldenstrôm's macroglobulinemia. Developmental and prognostic study]. Sem Hop (1975) 0.88
Genetic control of sensitivity to Moloney leukemia virus in mice. III. The three H-2 linked Rmv genes are immune response genes controlling the antiviral antibody response. Eur J Immunol (1980) 0.88
Identification of a pure splenic form of chronic lymphocytic leukaemia. Br J Haematol (1979) 0.87
Ectopic expression of murine TPO receptor (c-mpl) in mice is pathogenic and induces erythroblastic proliferation. Blood (1996) 0.87
DNA rearrangements proximal to the EVI1 locus associated with the 3q21q26 syndrome. Blood (1994) 0.87
Functional heterogeneity of B-CLL lymphocytes: dissociated responsiveness to growth factors and distinct requirements for a first activation signal. Blood (1987) 0.86
Detection of apoptosis at the single-cell level by direct incorporation of fluorescein-dUTP in DNA strand breaks. Biotechniques (1996) 0.86